Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant
| Autor: | Patricia A. Hughes, M. L. Lepow, Shawn A. Messer, Michael A. Pfaller, Holly Swanson |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
medicine.medical_specialty
Antifungal Agents Arthritis Microbial Sensitivity Tests fluids and secretions Amphotericin B hemic and lymphatic diseases Internal medicine Candida albicans Arthropathy Humans Medicine Fungemia Mycosis Arthritis Infectious biology business.industry Infant Newborn equipment and supplies bacterial infections and mycoses Fungal arthritis medicine.disease biology.organism_classification Karyotyping Concomitant Pediatrics Perinatology and Child Health Immunology Female Complication business Polymorphism Restriction Fragment Length |
| Zdroj: | The Journal of Pediatrics. 129:688-694 |
| ISSN: | 0022-3476 |
| DOI: | 10.1016/s0022-3476(96)70151-8 |
| Popis: | Fungal arthritis in pediatric patients is rare and is most often associated with hematogenous spread to the affected joint. It is generally seen concomitant with, or shortly after, fungemia. We report a case of an immunocompetent patient in whom candidal arthritis developed 1 year after initial fungemia. The initial candidiasis was considered to be adequately treated with amphotericin B. The Candida isolates from the neonatal fungemia and subsequent arthritis were the same as identified by electrophoretic karyotype, restriction fragment length polymorphism analysis, and antifungal susceptibility testing. Pediatric candidal fungemia, arthritis, and their treatments are discussed.(J Pediatr 1996;129:688-94) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect